pre-IPO PHARMA

COMPANY OVERVIEW

Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://adcentrx.com/


    CAREER WEBSITE

    https://adcentrx.com/careers/


    SOCIAL MEDIA


    INVESTORS

    cbc-group zoo-capital


    PRESS RELEASES


    Sep 27, 2023

    Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0706, a Novel ADC Targeting Nectin-4 for the Treatment of Advanced Solid Tumors


    Jul 17, 2023

    Adcentrx Therapeutics Announces FDA Clearance of Investigational New Drug Application for ADRX-0706, a Novel ADC Targeting Nectin-4 for the Treatment of Advanced Solid Tumors


    Apr 24, 2023

    Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures


    Apr 28, 2021

    Adcentrx Therapeutics Announces Completion of $50m Series A Financing Led By CBC Group To Accelerate Next-Generation Conjugate Drugs Research and Development


    For More Press Releases


    Google Analytics Alternative